Cargando…
The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia
The ongoing developments of psychiatric classification systems have largely improved reliability of diagnosis, including that of schizophrenia. However, with an unknown pathophysiology and lacking biomarkers, its validity still remains low, requiring further advancements. Research has helped establi...
Autores principales: | Misiak, Błażej, Samochowiec, Jerzy, Kowalski, Krzysztof, Gaebel, Wolfgang, Bassetti, Claudio L. A., Chan, Andrew, Gorwood, Philip, Papiol, Sergi, Dom, Geert, Volpe, Umberto, Szulc, Agata, Kurimay, Tamas, Kärkkäinen, Hilkka, Decraene, Andre, Wisse, Jan, Fiorillo, Andrea, Falkai, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486256/ https://www.ncbi.nlm.nih.gov/pubmed/37476977 http://dx.doi.org/10.1192/j.eurpsy.2023.2432 |
Ejemplares similares
-
Improving mental health care in depression: A call for action
por: Eder, Julia, et al.
Publicado: (2023) -
Transitions in mental health care: The European Psychiatric Association contribution to reform in Bulgaria
por: Beezhold, Julian, et al.
Publicado: (2020) -
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health
por: Vai, Benedetta, et al.
Publicado: (2022) -
EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021) -
EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)